Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in Tunisia

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

September 30, 2024

Conditions
Primary Immunodeficiency Diseases
Interventions
DEVICE

IgG deficiency rapid screening test

We will be testing patients who have already been diagnossed iwth primary immunodeficiency (PID) disease. there are 400 types of PID. We will test their blood before they receive antibody transfusion to evaluate the accuracy of our new screening test. We are trying to develop easy to use, low-cost screening tests for doctors to use with patients to detect those with low IgG levels before they are given the oral polio vaccine. These patients must be prioritized for intramuscular injections of a polio vaccine to prevent potential spread of wild type polio.

Trial Locations (1)

Unknown

National Bone Marrow Transplant center, Tunis

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Institut Pasteur de Tunis

OTHER

collaborator

Centre National de Greffe de Moelle Osseuse

OTHER_GOV

lead

PATH

OTHER

NCT05621876 - Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in Tunisia | Biotech Hunter | Biotech Hunter